Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.5504
-0.0032 (-0.58%)
Feb 4, 2026, 3:02 PM EST - Market open
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $37.17 million as of February 4, 2026. Its market cap has decreased by -25.82% in one year.
Market Cap
37.17M
Enterprise Value
-59.11M
1-Year Change
-25.82%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $37.17M, a decrease of -91.29%. That is a compound annual growth rate of -43.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 37.39M | 11.25% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 40.30M |
| NextCure | 39.26M |
| Anebulo Pharmaceuticals | 39.03M |
| Generation Bio Co. | 38.47M |
| Actinium Pharmaceuticals | 37.44M |
| Tvardi Therapeutics | 37.06M |
| RenovoRx | 37.02M |
| Atara Biotherapeutics | 36.34M |